onapristone
onapristone: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: Context Therapeutics Inc. (CNTX)
Development Pipeline (1)
| Company | Phase |
|---|---|
| Context Therapeutics Inc. (CNTX) | Phase 1/Phase 2 |
Clinical Trials (1)
An Open-Label, Phase 1b-2 Study of Elacestrant, in Combination With Onapristone in Patients With Estrogen Receptor-Positive, Progesterone Receptor-Positive, HER2-negative Advanced or Metastatic Breast Cancer (ELONA)
Frequently asked questions
Who is developing onapristone?
onapristone is being developed by Context Therapeutics Inc..
How many clinical trials involve onapristone?
BioSniper tracks 1 clinical trial involving onapristone.
Analyze Context Therapeutics Inc. & onapristone with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company